Concurrent use of mephedrone (4-methylmethcathinone; MEPH) and established drugs of abuse is now commonplace, but knowledge about interactions between these drugs is sparse. The present study was designed to test the hypothesis that prior MEPH exposure enhances the locomotor-stimulant effects of cocaine and methamphetamine (METH). For cocaine experiments, rats pretreated with saline, cocaine (15 mg/kg), or MEPH (15 mg/kg) for 5 days were injected with cocaine after 10 days of drug absence. For METH experiments, rats pretreated with saline, METH (2 mg/kg), or MEPH (15 mg/kg) were injected with METH after 10 days of drug absence. Cocaine challenge produced greater locomotor activity after pretreatment with cocaine or MEPH than after pretreatment with saline. METH challenge produced greater locomotor activity after METH pretreatment than after saline pretreatment; however, locomotor activity in rats pretreated with MEPH or saline and then challenged with METH was not significantly different. The locomotor response to MEPH (15 mg/kg) was not significantly affected by pretreatment with cocaine (15 mg/kg) or METH (0.5, 2 mg/kg). The present demonstration that cocaine-induced locomotor activation is enhanced by prior MEPH exposure suggests that MEPH cross-sensitizes to cocaine and increases cocaine efficacy. Interestingly, MEPH cross-sensitization was not bidirectional and did not extend to METH, suggesting that the phenomenon is sensitive to specific psychostimulants.
Introduction
Mephedrone (MEPH) shares structural and pharmacological features with abused psychostimulants and is highly popular among recreational drug users, especially in the UK, where it was recently identified as the sixth most frequently used drug of abuse (Winstock et al., 2011) . MEPH produces locomotor activation in rats but possesses a weaker locomotor stimulus than methamphetamine (METH) (Huang et al., 2012; Baumann et al., 2013) . MEPH increases extracellular dopamine and serotonin in the rat nucleus accumbens, with greater augmentation of serotonin (Kehr et al., 2011; Baumann et al., 2012 Baumann et al., , 2013 . Consistent with its reported psychoactive properties, MEPH produces conditioned place preference (Lisek et al., 2012) , is self-administered (Hadlock et al., 2011; Aarde et al., 2013) , and shows weak locomotor-sensitizing properties (Gregg et al., 2013) in laboratory animals. Polydrug abuse is commonly practiced among those taking MEPH with greater than 80% of MEPH users reporting the use of cocaine, amphetamine derivatives, alcohol, tobacco, and cannabis (Prosser and Nelson, 2012) . The present study was designed to test the hypothesis that prior MEPH exposure enhances the locomotor-stimulant effects of cocaine and METH.
Methods

Subject
Male Sprague-Dawley rats (260-290 g; Harlan Laboratories, Indianapolis, Indiana, USA) were housed two per cage and maintained on a 12-h light-dark cycle. Food and water were freely available. Animal use procedures were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and Institutional Guidelines for the Care of Animals.
Procedure
Doses, dosing schedules, and experimental paradigms were based on our previous work (Kovalevich et al., 2012; Gregg et al., 2013) . To investigate the effects of prior MEPH exposure on cocaine efficacy, rats were injected for 5 days with saline, cocaine (15 mg/kg), or MEPH (15 mg/kg) and challenged with cocaine (15 mg/kg) 10 days later. To examine effects of prior cocaine exposure on MEPH efficacy, rats were injected for 5 days with cocaine (15 mg/kg) or saline and were challenged with MEPH (15 mg/kg) 10 days later. MEPH/METH interactions were investigated in separate experiments. To investigate effects of prior MEPH exposure on METH efficacy, rats were injected with saline, METH (2 mg/kg), or MEPH (15 mg/kg) and challenged with METH (2 mg/kg) 10 days later. Effects of METH exposure on MEPH efficacy were investigated by injecting rats with saline or METH (0.5, 2 mg/kg) for 5 days and then challenging them with MEPH (15 mg/kg) 10 days later.
Locomotor activity was measured after psychostimulant challenge on the last day of injection. Rats were placed individually into activity chambers and allowed to acclimate for 60 min. Basal activity was then recorded for 30 min, followed by drug injection and recording of activity for at least 60 min. The Digiscan DMicro system (Accuscan Inc., Columbus, Ohio, USA) measured ambulatory activity as consecutive beam breaks resulting from horizontal movement and nonambulatory activity as repetitive beam breaks (Lisek et al., 2012) . Eight rats per group were used.
Drugs
Racemic MEPH was synthesized by Dr Allen Reitz. Cocaine hydrochloride and METH were provided by NIDA. Drugs were dissolved in saline and injected intraperitoneally.
Statistical analysis
Temporal data were analyzed with a two-way analysis of variance (treatment, time) or Student's t-test. Cumulative data were analyzed by a one-way analysis of variance or Student's t-test. Group differences were identified with Bonferroni's or Dunnett's test. P value less than 0.05 was considered statistically significant.
Results
Effects of MEPH or cocaine exposure on cocaine-induced locomotor activity are shown in Fig. 1a . Significant main effects of treatment [F(2,21) = 23.52, P < 0.001] and time [F(12,273) = 32.67, P < 0.001] and a significant interaction [F(24,273) = 3.39, P < 0.001] were identified for temporal data. A significant main effect [F(2,21) = 6.65, P < 0.01] was identified for cumulative data (30 min after injection; Fig. 1a , box). Post-hoc analysis of cumulative data indicated that cocaine produced greater locomotor activity in MEPH-exposed (P < 0.05) or cocaine-exposed (P < 0.01) rats compared with previously drug-naive rats; further, no difference in cocaine-induced locomotor activity was detected between rats previously treated with cocaine or MEPH (P > 0.05). Similar effects were observed for time-course data, in that MEPH-exposed or cocaine-exposed rats showed enhanced locomotor activation after cocaine challenge compared with saline-pretreated controls. Results of the converse situation (effects of prior cocaine exposure on MEPH efficacy) are presented in Fig. 1b . Analysis of temporal and cumulative data revealed that locomotor activity induced by MEPH challenge was not different in rats pretreated with saline or cocaine (P > 0.05).
Effects of METH/MEPH interactions are shown in Fig. 2 . For METH-induced hyperlocomotion ( Fig. 2a ), significant main effects of prior MEPH or METH treatment [F(2,21) = 177.9, P < 0.001] and time [F(18,399) = 9.85, P < 0.001], as well as a significant interaction [F(36,399) = 1.80, P < 0.01], were identified. For cumulative data (60 min after injection) a significant main effect [F(2,21) = 27.52, P < 0.001] was identified ( Fig. 2a, box) . Post-hoc analysis indicated that METH produced greater locomotor activity in rats previously treated with METH than in rats previously treated with MEPH or saline (P < 0.001). Locomotor activity induced by METH challenge was not different after pretreatment with MEPH or saline (P < 0.05). For the converse situation (effect of prior METH exposure on MEPH efficacy; Fig. 2b ), analysis of temporal and cumulative data indicated that locomotor activity induced by MEPH challenge (15 mg/kg) was not different after pretreatment with saline or METH (0.5, 2 mg/kg, P > 0.05).
Discussion
Our study revealed that prior MEPH exposure enhances the locomotor-stimulant properties of cocaine and crosssensitizes to cocaine. Behavioral cross-sensitization has been established between several psychostimulants, including cocaine and amphetamine (Brandon et al., 2001) , methylphenidate and amphetamine , and methylphenidate and cocaine (Achat-Mendes et al., 2003) . The mechanism underlying MEPH crosssensitization with cocaine is unclear. A general explanation for cross-sensitization between two drugs that is that they act through overlapping mechanisms, but the phenomenon, even for established psychostimulants, is poorly understood. Cocaine itself shows strong behavioral sensitizing properties (Pierce et al., 1996; Steketee and Kalivas, 2011) , whereas MEPH possesses weaker motor-sensitizing properties, with preferential effects on stereotypical activity, that are nonetheless consistent across multiple doses, dosing schedules, and contexts (Gregg et al., 2013) . MEPH and cocaine enhance brain stimulation reward to similar extents (Robinson et al., 2012) . In drug discrimination studies, MEPH fully substitutes for the discriminative stimulus effects of cocaine (Gatch et al., 2013) , and cocaine partially substitutes for the discriminative stimulus effects of MEPH (Varner et al., 2013) . One explanation for the locomotor cross-sensitization observed here is that cocaine and MEPH produce overlapping increases in extracellular dopamine but through separable mechanisms (Kehr et al., 2011) ; MEPH is a substrate of plasma membrane monoamine transporters and produces depolarizing currents at the dopamine transporter similar to dopamine-releasing agents (e.g. METH), whereas cocaine is a dopamine uptake blocker (Cameron et al., 2013) . Additive, or synergistic, drug-drug interactions are often most pronounced in cases in which individual drugs administered in combination produce qualitatively similar effects but through distinguishable pharmacological mechanisms (Tallarida, 2011) . Thus, in the present case, a synergistic increase in dopamine transmission following combined administration of a dopamine releaser (MEPH) and a dopamine uptake blocker (cocaine) may have facilitated MEPH cross-sensitization with cocaine.
Contrary to our hypothesis, MEPH and METH did not show cross-sensitization. The reason for the lack of locomotor interaction is unknown, but it should be noted that the neuropharmacological profile of MEPH is often compared with that of MDMA (ecstasy), and that crossover effects of MDMA are more consistent with cocaine than with amphetamine derivatives (Modi et al., 2006) . For example, MDMA pretreatment enhances behavioral responses to cocaine (Morgan et al., 1997; Kalivas et al., 1998; Fletcher et al., 2001; Achat-Mendes et al., 2003; Itzhak et al., 2003) , whereas crossover between MDMA and amphetamines is more variable, with no effect (Cole et al., 2003; Cornish et al., 2003; Modi et al., 2006) and positive (Callaway and Geyer, 1992 ) effects reported. The lack of interaction, as discussed above, may be related to the fact that MEPH and METH are both dopamine transporter substrates, as opposed to the combination of MEPH and cocaine that consists of a dopamine releaser and a dopamine uptake blocker. Finally, the most parsimonious explanation may be that cross-sensitization studies are highly dependent on dose, dosing schedule, experimental paradigm (e.g. repeated exposure interval, withdrawal period, administration context, etc.), and species/strain. The identification of behavioral crossover, such as that observed between cocaine and MEPH, can indeed provide a foundation for studying the underlying mechanism. Conversely, despite the use of relatively equieffective doses of MEPH and METH and testing of low and high doses of METH, the possibility that different doses or paradigms might have yielded a different outcome cannot be excluded.
In summary, our behavioral data indicate that MEPH crosssensitizes to cocaine and that prior exposure to MEPH increases the locomotor effects of cocaine. Although these results suggest that MEPH interacts additively or synergistically with cocaine in vivo, more rigorous dose-combination studies directed toward specific endpoints (e.g. addiction, neurotoxicity, cardiotoxicity) are now required to better quantify the MEPH-cocaine interaction and determine whether the interaction poses enhanced health risks to polydrug abusers who take cocaine and MEPH. For example, assays such as self-administration and conditioned place preference could be used to determine whether the positive reinforcing efficacy of a combination of MEPH and cocaine is greater than that of either cocaine or MEPH by itself. Finally, because drug abusers often consume a cocktail of designer cathinones, experimental studies testing the impacts of combinations of synthetic cathinones, such as MEPH + methylone or MEPH + methylenedioxypyrovalerone, are needed to better understand the clinical hazards of bath salts.
